Clinical Trials in Austin

Showing 14801-14820 of 15,205 trials

Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

NCT00637793

The purpose of this study is to evaluate the effectiveness of NGX267 in the improvement of decreased salivary flow associated with primary or secondary Sjögren's syndrome. For each patient, the study includes four periods of treatment separated by a washout period that may range from 4 - 8 days according to patient and site discretion. Each treatment period includes two overnight stays in the clinic. One dose of study drug is taken during each treatment period

XerostomiaSjogren's Syndrome

TorreyPines Therapeutics24 participantsStarted Feb 2008

Duncansville, Pennsylvania, United States • Philadelphia, Pennsylvania, United States • Austin, Texas, United States

COMPLETEDPhase 2< 1 mile

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

NCT00116610

This is a Phase II research study that is designed for patients who have small cell lung cancer (SCLC) that is no longer responding to treatment. Patients will receive picoplatin, a new platinum-based agent that is currently under investigation, in 21-day cycles.

Small Cell Lung Cancer

Poniard Pharmaceuticals75 participantsStarted Jun 2005

Hot Springs, Arkansas, United States • Los Angeles, California, United States • Palm Springs, California, United States +52 more locations

Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Find Trials by Condition in Austin

A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery

Basiliximab in Moderate to Severe Ulcerative Colitis

CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Hypertension Screening and Treatment Program

Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1